Soo-Hyun Sung

Prof. Dr. Soo-Hyun Sung

National Development Institute of Korean Medicine, Gyeongsan-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2022 in Toxins
Verified
Journal Article
Open access
PDF file
NKNayoen Kwon
Nayoen Kwon
SSSoo-Hyun Sung
Soo-Hyun Sung
HSHyun Kyung Sung
Hyun Kyung Sung
JPJang-Kyung Park
Jang-Kyung Park
While the survival rate has increased due to treatments for breast cancer, the quality of life has decreased because of the side effects of chemotherapy. Various toxins are being developed as alternative breast cancer treatments, and bee venom is drawing attention as one of them. We analyzed the effect of bee venom and its components on breast cancer cells and reviewed the mechanism underlying the anticancer effects of bee venom. Data up to March 2022 were searched from PubMed, EMBASE, OASIS, KISS, and Science Direct online databases, and studies that met the inclusion criteria were reviewed. Among 612 studies, 11 were selected for this research. Diverse drugs were administered, including crude bee venom, melittin, phospholipase A2, and their complexes. All drugs reduced the number of breast cancer cells in proportion to the dose and time. The mechanisms of anticancer effects included cytotoxicity, apoptosis, cell targeting, gene expression regulation, and cell lysis. Summarily, bee venom and its components exert anticancer effects on human breast cancer cells. Depending on the mechanisms of anticancer effects, side effects are expected to be reduced by using various vehicles. Bee venom and its components have the potential to prevent and treat breast cancer in the future.

1 February 2021 in Toxins
Verified
Journal Article
Open access
PDF file
SSSoo-Hyun Sung
Soo-Hyun Sung
JKJi-Won Kim
Ji-Won Kim
JHJi-Eun Han
Ji-Eun Han
BSByung-Cheul Shin
Byung-Cheul Shin
JPJang-Kyung Park
Jang-Kyung Park
GLGihyun Lee
Gihyun Lee
Animal venoms, widespread throughout the world, are complex mixtures, the composition of which depends on the venom-producing species. The objective of this study was to contribute to the development of animal venom-based medicines by investigating the use of animal venom pharmacopuncture in Korean medicine (KM) institutions. We surveyed 256 public health centers from 1 through 31 October 2019 as guided by the Ministry of Health and Welfare (MoHW). A questionnaire developed by an expert group was distributed and collected for statistical analysis. The survey identified three types of animal venom-based pharmacopuncture: bee, snake, and toad venoms. The medications are based on a single animal venom ingredient and produced in 11 external herbal dispensaries (EHDs). Each animal venom is processed, refined, and freeze-dried in a cleanroom to produce a powder formulation that is later measured, diluted, filtered, filled, sealed, sterilized, and packaged as pharmacopuncture injections used in KM institutions. Bee venom therapy is effective in treating musculoskeletal pain, snake venom therapy is effective in controlling bleeding during surgery, and toad venom therapy is effective in cancer treatment. The study suggests that bee, snake, and toad venoms could be used in medical institutions and have the potential for drug development.

29 August 2021 in Toxins
Verified
Journal Article
Open access
PDF file
SSSoo-Hyun Sung
Soo-Hyun Sung
GLGihyun Lee
Gihyun Lee
Bee venom (BV) is a complex natural toxin that contains various pharmaceutical compounds. Bee venom acupuncture (BVA), involving a BV injection into a certain acupuncture point, has been utilized to relieve a range of pain conditions. Regardless of whether pain is caused by disease or injury, if not effectively treated, pain can exert a detrimental effect on all aspects of life. In the past decade, many researchers have investigated the anti-nociceptive effects of BVA through clinical use and experimental evaluation. This report reviews the existing knowledge on the analgesic effects of BVA, focusing on musculoskeletal pain, inflammatory pain and neuropathic pain, and its analgesic mechanisms. Although further clinical trials are needed to clinical application of experimental results, this review will contribute to the standardization and generalization of BVA.

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SSSoo-Hyun Sung
Soo-Hyun Sung
ASAngela-Dong-Min Sung
Angela-Dong-Min Sung
HSHyun-Kyung Sung
Hyun-Kyung Sung
TATteul-E-Bom An
Tteul-E-Bom An
KKKyeong Han Kim
Kyeong Han Kim
JPJang-Kyung Park
Jang-Kyung Park
Aim of the Study. This systematic review and meta‐analysis aims to evaluate the current evidence from randomized controlled trials (RCTs) related to the effectiveness and safety of acupuncture treatment (AT), including electroacupuncture or thread‐embedding therapy in combination with modern technology, for chronic pelvic pain (CPP) in women. Materials and Methods. We searched 12 electronic databases up to December 2017. All randomized controlled trials evaluating the effect of AT for CPP were considered. Results. Four RCTs with 474 participants were included. The methodological quality of included studies was generally low. The results of meta‐analysis of two studies showed that AT combined with conventional treatment (CT) was associated with significantly reduced CPP, based on the total effectiveness rate (n=277, mean difference = 1.29, confidence interval = 1.13 to 1.47, P=0.0001, I2 = 0%). Conclusions. This review suggests the potential of AT combined with CT compared to CT alone for treating female CPP. However, there is insufficient evidence to conclude that AT can be recommended as a complementary and alternative (CAM) treatment for women with CPP. To draw a firm conclusion, future studies should require not only lager, more rigorously designed RCTs but also research on different AT types. Protocol Registration Number. This study is registered with PROSPERO 2018 (CRD42018088627).

30 June 2019 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
PDF file
SSSoo-Hyun Sung
Soo-Hyun Sung
BSByung-Cheul Shin
Byung-Cheul Shin
MPMin-Jung Park
Min-Jung Park
KKKyeong Han Kim
Kyeong Han Kim
JKJi-Won Kim
Ji-Won Kim
JPJang-Kyung Park
Jang-Kyung Park
Soo-Hyun Sung, Byung-Cheul Shin, Min-Jung Park, Kyeong Han Kim, Ji-Won Kim, Ji-Yeon Ryu, and Jang-Kyung Park. J Pharmacopuncture 2019;22:75-82. https://doi.org/10.3831/KPI.2019.22.009

10 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SKSe-Mi Kang
Se-Mi Kang
JWJae-Hee Won
Jae-Hee Won
JHJi-Eun Han
Ji-Eun Han
JKJong-Hyun Kim
Jong-Hyun Kim
KKKyeong-Han Kim
Kyeong-Han Kim
SSSoo-Hyun Sung
Soo-Hyun Sung
The presence of pesticide residues in herbs and the herbal products derived from them raises serious health concerns. This study was conducted to investigate the residual pesticide concentrations and assess potential human health risks from herbal medicines used in traditional Korean medicine clinics. A total of 40 samples of herbal decoctions were collected from 10 external herbal dispensaries. The pesticide residues were analyzed by the multiresidue method for 320 different pesticides using liquid chromatography tandem mass spectrometry (LC-MS/MS) and gas chromatography tandem mass spectrometry (GC-MS/MS). As a result of the monitoring, carbendazim was detected at 0.01 and 0.03 μg/g in eight samples and no pesticide was detected in the other herbal decoctions. Carbendazim was set for each individual item as less than 0.05 μg/g in Paeoniae radix, less than 0.05 μg/g in Cassiae semen, less than 2.0 μg/g in Lycii fructus, and less than 10 μg/g in Schisandrae fructus (dried). Therefore, the results of this study suggested that the detected pesticide residues in herbal decoctions could not be considered as posing a serious health risk.